1.Clinical Observation of Xiere Xingpi Yin in Treatment of Simple Obesity and Effect on Obesity-related miRNAs
Yelin ZHU ; Yiwen HUANG ; Ke ZHANG ; Xianchang ZENG ; Zhenxiu LIU ; Hejin LAI ; Feng TAO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):177-185
ObjectiveTo observe the effects of Xiere Xingpi Yin (XRXPY) on the body mass and body fat distribution in patients with simple obesity, and to preliminarily explore whether the mechanism involves the regulation of specific obesity-related microRNAs (miRNAs). MethodsA randomized controlled trial design was employed to recruit patients with simple obesity diagnosed with the traditional Chinese medicine (TCM) syndrome of dampness-heat accumulating in the spleen. Using a randomized controlled trial design, 95 patients with simple obesity of dampness-heat encumbering the Spleen syndrome were recruited, after 3 were excluded, 92 were randomly assigned in a 1∶1 ratio by means of a random number table. On the basis of lifestyle intervention, the observation group received XRXPY granules, while the control group received a placebo. Serum samples and TCM symptom scores were collected before and after the 12-week observation period. Differences in body mass loss, body composition, lipid metabolism, and TCM symptom scores were compared between the groups. An obesity-related miRNA dataset was constructed by searching the Human MicroRNA Disease Database. Library construction, sequencing, and quality control were performed on 6 selected patients from each group to screen the differentially expressed miRNAs. The intersection of these miRNAs with the obesity-related miRNAs was verified by bioinformatics and correlation analysis. ResultsBaseline characteristics were comparable between the two groups before treatment. A total of 86 patients completed the study (42 cases in the observation group and 44 cases in the control group). The proportion of patients achieving ≥5% body weight reduction was significantly higher in the observation group than in the control group 81.0% (34/42) vs. 43.2% (19/44) (χ2=12.963, P<0.01). Compared with baseline within the observation group, body weight, waist circumference, and TCM syndrome score were significantly decreased (P<0.01), as were body fat percentage (P<0.01) and serum triglyceride level (P<0.05). Compared with the control group after treatment, waist circumference and TCM syndrome score were significantly lower in the observation group (P<0.01), and body weight showed a trend toward reduction. When changes from baseline were compared between the two groups, the magnitudes of decrease in body weight, waist circumference, and TCM syndrome score were all significantly greater in the observation group than in the control group (P<0.01). With respect to safety, no serious adverse events occurred in either group and no participant discontinued the study because of adverse events. Compared with baseline, alanine aminotransferase levels decreased significantly in both the control and observation groups (P<0.01), and urea decreased significantly in the observation group (P<0.01), indicating a favorable safety profile. Sequencing identified nine differentially expressed miRNAs. After intersecting with the obesity-related miRNA dataset (187 miRNAs), 3 miRNAs were identified: miR-221 (log2FC=-6.62, P=0.009), miR-29a (log2FC=6.33, P=0.016), and miR-10b (log2FC=-5.91, P=0.029). A total of 262 target genes of the 3 miRNAs were identified, which were significantly enriched in 67 pathways, including the lysine degradation pathway (P=0.001). Correlation analysis revealed a positive correlation between miR-221 and triglycerides (r=0.46, P=0.027), a negative correlation between miR-29a and waist-to-hip ratio (r=-0.41, P=0.047), and positive correlations of miR-10b with body fat percentage (r=0.49, P=0.014) and waist circumference (r=0.44, P=0.032). ConclusionXRXPY combined with lifestyle intervention can effectively reduce the body mass and improve body composition. The underlying mechanism may involve the regulation of the lysine degradation pathway via miR-221, miR-29a, and miR-10b, though further verification is required.
2.Clinical Observation of Xiere Xingpi Yin in Treatment of Simple Obesity and Effect on Obesity-related miRNAs
Yelin ZHU ; Yiwen HUANG ; Ke ZHANG ; Xianchang ZENG ; Zhenxiu LIU ; Hejin LAI ; Feng TAO
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(21):177-185
ObjectiveTo observe the effects of Xiere Xingpi Yin (XRXPY) on the body mass and body fat distribution in patients with simple obesity, and to preliminarily explore whether the mechanism involves the regulation of specific obesity-related microRNAs (miRNAs). MethodsA randomized controlled trial design was employed to recruit patients with simple obesity diagnosed with the traditional Chinese medicine (TCM) syndrome of dampness-heat accumulating in the spleen. Using a randomized controlled trial design, 95 patients with simple obesity of dampness-heat encumbering the Spleen syndrome were recruited, after 3 were excluded, 92 were randomly assigned in a 1∶1 ratio by means of a random number table. On the basis of lifestyle intervention, the observation group received XRXPY granules, while the control group received a placebo. Serum samples and TCM symptom scores were collected before and after the 12-week observation period. Differences in body mass loss, body composition, lipid metabolism, and TCM symptom scores were compared between the groups. An obesity-related miRNA dataset was constructed by searching the Human MicroRNA Disease Database. Library construction, sequencing, and quality control were performed on 6 selected patients from each group to screen the differentially expressed miRNAs. The intersection of these miRNAs with the obesity-related miRNAs was verified by bioinformatics and correlation analysis. ResultsBaseline characteristics were comparable between the two groups before treatment. A total of 86 patients completed the study (42 cases in the observation group and 44 cases in the control group). The proportion of patients achieving ≥5% body weight reduction was significantly higher in the observation group than in the control group 81.0% (34/42) vs. 43.2% (19/44) (χ2=12.963, P<0.01). Compared with baseline within the observation group, body weight, waist circumference, and TCM syndrome score were significantly decreased (P<0.01), as were body fat percentage (P<0.01) and serum triglyceride level (P<0.05). Compared with the control group after treatment, waist circumference and TCM syndrome score were significantly lower in the observation group (P<0.01), and body weight showed a trend toward reduction. When changes from baseline were compared between the two groups, the magnitudes of decrease in body weight, waist circumference, and TCM syndrome score were all significantly greater in the observation group than in the control group (P<0.01). With respect to safety, no serious adverse events occurred in either group and no participant discontinued the study because of adverse events. Compared with baseline, alanine aminotransferase levels decreased significantly in both the control and observation groups (P<0.01), and urea decreased significantly in the observation group (P<0.01), indicating a favorable safety profile. Sequencing identified nine differentially expressed miRNAs. After intersecting with the obesity-related miRNA dataset (187 miRNAs), 3 miRNAs were identified: miR-221 (log2FC=-6.62, P=0.009), miR-29a (log2FC=6.33, P=0.016), and miR-10b (log2FC=-5.91, P=0.029). A total of 262 target genes of the 3 miRNAs were identified, which were significantly enriched in 67 pathways, including the lysine degradation pathway (P=0.001). Correlation analysis revealed a positive correlation between miR-221 and triglycerides (r=0.46, P=0.027), a negative correlation between miR-29a and waist-to-hip ratio (r=-0.41, P=0.047), and positive correlations of miR-10b with body fat percentage (r=0.49, P=0.014) and waist circumference (r=0.44, P=0.032). ConclusionXRXPY combined with lifestyle intervention can effectively reduce the body mass and improve body composition. The underlying mechanism may involve the regulation of the lysine degradation pathway via miR-221, miR-29a, and miR-10b, though further verification is required.
3.Efficacy Mechanism of Xianlian Jiedu Prescription Against Colorectal Cancer Recurrence vias Regulating Angiogenesis
Yanru XU ; Lihuiping TAO ; Jingyang QIAN ; Weixing SHEN ; Jiani TAN ; Chengtao YU ; Minmin FAN ; Changliang XU ; Yueyang LAI ; Liu LI ; Dongdong SUN ; Haibo CHENG
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(6):79-87
ObjectiveTo explore effect of Xianlian Jiedu prescription on the recurrence of colorectal cancer (CRC) and investigate the related mechanisms. MethodsA postoperative recurrence model was established in 25 Balb/c mice by injecting CT26 cells subcutaneously into the armpit, followed by surgical removal of 99% of the subcutaneous tumor. The mice were randomly divided into model group, low-dose Xianlian Jiedu prescription (XLJDP-L) group (6.45 g·kg-1·d-1), medium-dose Xianlian Jiedu prescription (XLJDP-M) group (12.9 g·kg-1·d-1), high-dose Xianlian Jiedu prescription (XLJDP-H) group (25.8 g·kg-1·d-1), and 5-fluorouracil (5-FU) group (1×10-3 g·kg-1·d-1). The mice were euthanized after 14 days of continuous intervention, and recurrent tumor tissue was harvested. Hematoxylin and eosin (HE) staining was used to observe pathological and morphological changes in the recurrent tumor tissue. Immunohistochemistry (IHC) was employed to assess the expression of proliferating cell nuclear antigen (Ki67), vascular endothelial growth factor (VEGF), and platelet-endothelial cell adhesion molecule (CD31) in recurrent tumor tissue. The Western blot was used to detect the protein expression levels of angiopoietin-2 (ANG-2), VEGF, phosphorylated-protein kinase B (p-Akt), protein kinase B (Akt), phosphorylated-phosphatidylinositol 3-kinase (p-PI3K), and phosphatidylinositol 3-kinase (PI3K) in recurrent tumor tissue. ResultsBefore treatment, there were no statistical differences in tumor volume, tumor weight, and body mass among the XLJDP-L, XLJDP-M, and XLJDP-H groups and the 5-FU group compared to the model group, indicating model stability. After treatment, compared with those in the model group, the tumor volume and tumor weight in the XLJDP-L, XLJDP-M, and XLJDP-H groups and the 5-FU group were significantly reduced (P<0.01), showing dose dependency. Meanwhile, there were no significant differences in body weight among the XLJDP-L, XLJDP-M, and XLJDP-H groups and the 5-FU group compared to the model group. HE staining showed that compared with that in the model group, tumor tissue in the XLJDP-L, XLJDP-M, and XLJDP-H groups and the 5-FU group had loosely arranged cells, increased intercellular spaces, small and shriveled nuclei, light staining, fewer mitotic figures and atypical nuclei, and increased necrotic areas. IHC showed that compared with those of the model group, the positive rates of Ki67, VEGF, and CD31 in the recurrent tumor tissue of the XLJDP-L, XLJDP-M, and XLJDP-H groups and the 5-FU group were significantly reduced (P<0.01) in a dose-dependent manner. Western blot results showed that compared with those of the model group, the protein expression levels of ANG-2 and VEGF in the recurrent tumor tissue of the XLJDP-L, XLJDP-M, and XLJDP-H groups and the 5-FU group were significantly downregulated (P<0.05, P<0.01), and the p-Akt/Akt and p-PI3K/PI3K ratios were significantly decreased in a dose-dependent manner (P<0.05, P<0.01). ConclusionXianlian Jiedu prescription significantly inhibits the recurrence of CRC in mice after subcutaneous tumor surgery. The mechanism may involve regulating the PI3K/Akt pathway and downregulating key angiogenic proteins such as ANG-2, VEGF, and CD31.
4.Efficacy and dose-response relationships of antidepressants in the acute treatment of major depressive disorders: a systematic review and network meta-analysis.
Shuzhe ZHOU ; Pei LI ; Xiaozhen LYU ; Xuefeng LAI ; Zuoxiang LIU ; Junwen ZHOU ; Fengqi LIU ; Yiming TAO ; Meng ZHANG ; Xin YU ; Jingwei TIAN ; Feng SUN
Chinese Medical Journal 2025;138(12):1433-1438
BACKGROUND:
The optimal antidepressant dosages remain controversial. This study aimed to analyze the efficacy of antidepressants and characterize their dose-response relationships in the treatments of major depressive disorders (MDD).
METHODS:
We searched multiple databases, including the Embase, Cochrane Central Register of Controlled Trials, PubMed, and Web of Science, for the studies that were conducted between January 8, 2016, and April 30, 2023. The studies are double-blinded, randomized controlled trials (RCTs) involving the adults (≥18 years) with MDD. The primary outcomes were efficacy of antidepressant and the dose-response relationships. A frequentist network meta-analysis was conducted, treating participants with various dosages of the same antidepressant as a single therapy. We also implemented the model-based meta-analysis (MBMA) using a Bayesian method to explore the dose-response relationships.
RESULTS:
The network meta-analysis comprised 135,180 participants from 602 studies. All the antidepressants were more effective than the placebo; toludesvenlafaxine had the highest odds ratio (OR) of 4.52 (95% confidence interval [CI]: 2.65-7.72), and reboxetine had the lowest OR of 1.34 (95%CI: 1.14-1.57). Moreover, amitriptyline, clomipramine, and reboxetine showed a linear increase in effect size from low to high doses. The effect size of toludesvenlafaxine increased significantly up to 80 mg/day and subsequently maintained the maximal dose up to 160 mg/day while the predictive curves of nefazodone were fairly flat in different dosages.
CONCLUSIONS:
Although most antidepressants were more efficacious than placebo in treating MDD, no consistent dose-response relationship between any antidepressants was observed. For most antidepressants, the maximum efficacy was achieved at lower or middle prescribed doses, rather than at the upper limit.
REGISTRATION
No. CRD42023427480; https://www.crd.york.ac.uk/prospero/display_record.php?
Humans
;
Antidepressive Agents/therapeutic use*
;
Depressive Disorder, Major/drug therapy*
;
Dose-Response Relationship, Drug
;
Randomized Controlled Trials as Topic
5.Clinical observation on the therapeutic effect of Xuanyunyihao formula on patients with phlegm-dampness obstruction type of vertigo
Ran TAO ; Linna PAN ; Zefei LAI
China Modern Doctor 2025;63(32):54-57
Objective To explore the clinical effect of Xuanyunyihao formula on patients with phlegm-dampness obstruction type of vertigo.Methods A total of 80 patients with phlegm-dampness obstruction type of vertigo treated at Jiangxi Hospital of Integrated Traditional Chinese and Western Medicine from July 2023 to March 2025.Participants were divided into control group(n=40)and observation group(n=40)using a random number table.The patients of control group received standard Western medical treatment,while the patients of observation group additionally received Xuanyunyihao formula.Both groups underwent continuous treatment for 14 days.The clinical efficacy,traditional chinese medicine(TCM)syndrome scores,nystagmus electro-oculogram(EOG)positive rates,and adverse reaction incidence were compared between two groups.Results The total effective rate of treatment in observation group was higher than that in control group,and the positive rate of EOG was lower than that in the control group(P<0.05).Compared with control group,the TCM syndrome score of observation group was lower after treatment(P<0.05).Conclusion Xuanyunyihao formula has a good effect on dizziness patients with phlegm-dampness obstruction type of vertigo,which is helpful to improve the clinical symptoms of patients,reduce the positive rate of EOG,and has good safety.
6.A multicenter clinical study on intramedullary vancomycin injection for preventing periprosthetic joint infection in total knee arthroplasty
Te LIU ; Jun FU ; Shiguang LAI ; Zhuo ZHANG ; Chi XU ; Lei GENG ; Yang LUO ; Peng REN ; Xin ZHI ; Quanbo JI ; Heng ZHANG ; Runkai ZHAO ; Haichao REN ; Ye TAO ; Qingyuan ZHENG ; Zeyu FENG ; Jianfeng YANG ; Yiming WANG ; Pengcheng LI ; Shuai LIU ; Wei CHAI ; Xiang LI ; Huiwu LI ; Xiaogang ZHANG ; Baochao JI ; Xianzhe LIU ; Xinzhan MAO ; Jianbing MA ; Xiangxiang SUN ; Jiying CHEN ; Yonggang ZHOU ; Jinliang WANG ; Weijun WANG ; Guoqiang ZHANG ; Ming NI
Chinese Journal of Orthopaedics 2025;45(12):803-811
Objective:To explore the safety and efficacy of intraosseous regional administration (IORA) of vancomycin for preventing infection in primary total knee arthroplasty (TKA).Methods:A total of 124 patients with knee osteoarthritis undergoing TKA between February 2024 and May 2024 at nine hospitals were enrolled. Preoperative infection prophylaxis involved either IORA (0.5 g vancomycin administered via intraosseous regional infusion before incision) or intravenous infusion (1 g vancomycin via peripheral vein). The IORA group included 15 males and 47 females with a median age of 66.5 years (range, 60.0-70.0 years), while the intravenous group included 14 males and 48 females with a median age of 66.0 years (range, 61.8-70.3 years) years. Intraoperative samples were collected including fat and synovium tissues after incision, before prosthesis placement, and after tourniquet release; distal femoral cancellous bone during femoral osteotomy; proximal tibial cancellous bone during tibial osteotomy; proximal intercondylar cancellous bone before prosthesis placement; and peripheral blood from non-infused arms at surgery initiation and after tourniquet release. Vancomycin concentrations were measured using liquid chromatography-tandem mass spectrometry. Vital sign changes were recorded from admission to 5~10 minutes post-IORA (IORA group) or post-incision (intravenous group). Follow-ups were conducted on postoperative day 1 and 3, and at 1 and 3 months, to document complications including IORA-related adverse events, periprosthetic joint infections, surgical site infections, red man syndrome, acute kidney injury, deep vein thrombosis and so on.Results:Vancomycin concentrations in bone, fat, and synovial tissue samples were significantly higher in the IORA group than in the intravenous group ( P<0.05), while vancomycin concentrations in blood samples were significantly lower in the IORA group than in the intravenous group ( P<0.05). Only 7.3%(41/558) of tissue samples in the IORA group had vancomycin concentrations below 2.0 μg/g (the minimum inhibitory concentration of vancomycin against coagulase-negative staphylococcus), compared to 59.3%(331/558) in the intravenous group (χ 2=11.285, P<0.001). In the intravenous group, 16.9%(21/124) of blood samples had vancomycin concentrations exceeding 15.0 mg/L (the threshold associated with a significantly increased risk of nephrotoxicity), while all concentrations in the IORA group were below this threshold, the difference was statistically significant (χ 2=22.943, P<0.001). There were no statistically significant difference ( P>0.05) in vital signs changes before and after vancomycin administration between the two groups. Two patients in the intravenous group experienced incision exudate, while no other related complications occurred in either group. Conclusions:Compared to the traditional intravenous infusion of 1 g vancomycin, intraosseous injection of a low dose (0.5 g) of vancomycin achieves higher local tissue concentrations in the knee joint with a lower incidence of adverse reactions and is safe for infection prophylaxis. Despite guidelines not recommending the routine use of vancomycin for preventing infection after primary TKA, intraosseous injection of 0.5 g vancomycin may be considered intraoperatively for primary TKA in the following scenarios: patients in medical institutions with a high prevalence of methicillin-resistant staphylococcus aureus (MRSA) infections, patients with potential preoperative MRSA colonization, or patients with cephalosporin allergy.
7.Research progress on correlation between circadian rhythm disturbance and work-related musculoskeletal disorders
Lichong LAI ; Pinyue TAO ; Dejing FAN ; Shuyu LU ; Jie PENG ; Huiqiao HUANG
Journal of Environmental and Occupational Medicine 2025;42(3):319-324
Circadian rhythm refers to the 24-hour periodic changes in behavior, physiology, and molecular processes in the human body. Disruptions to the circadian rhythm not only affect mental health but are also associated with various metabolic disorders, including the regulation of bone and muscle metabolism. Research has shown that work-related musculoskeletal disorders (WMSDs) are influenced not only by workload but also by circadian rhythm factors, such as shift work. This review examined the relationships between circadian rhythm-related antecedents, outcomes, and WMSDs, exploring their shared metabolic markers and mechanisms. It provided a systematic overview of the intrinsic connection between circadian rhythm disruptions and WMSDs. While current studies highlight the impact of circadian rhythm disturbances on musculoskeletal disorders, further investigation is required to address the confounding factors involved. Future research should integrate chronobiology with both subjective and objective data to explore the pathway from environmental factors to intermediate phenotypes to diseases, ultimately providing a more comprehensive understanding of the network mechanisms underlying WMSDs.
8.Research progress on molecular mechanisms of ginsenosides in alleviating acute lung injury.
Han-Yang ZHAO ; Xun-Jiang WANG ; Qiong-Wen XUE ; Bao-Lian XU ; Xu WANG ; Shu-Sheng LAI ; Ming CHEN ; Li YANG ; Zheng-Tao WANG ; Li-Li DING
China Journal of Chinese Materia Medica 2025;50(16):4451-4470
Acute lung injury(ALI) is a critical clinical condition primarily characterized by refractory hypoxemia and infiltration of inflammatory cells in lung tissue, which can progress into a more severe form known as acute respiratory distress syndrome(ARDS). Immune cells and inflammatory cytokines play important roles in the progression of the disease. Due to its unclear pathogenesis and the lack of effective clinical treatments, ALI is associated with a high mortality rate and severely affects patients' quality of life, making the search for effective therapeutic agents particularly urgent. Ginseng Radix et Rhizoma, the dried root of the perennial herb Panax ginseng from the Araliaceae family, contains active ingredients such as saponins and polysaccharides, which possess various pharmacological effects including anti-tumor activity, immune regulation, and metabolic modulation. In recent years, studies have shown that ginsenosides exhibit notable effects in reducing inflammation, ameliorating epithelial and endothelial cell injury, and providing anticoagulant action, indicating their comprehensive role in alleviating lung injury. This review summarizes the pathogenesis of ALI and the molecular mechanisms through which ginsenosides act at different stages of ALI development. The aim is to provide a scientific reference for the development of ginsenoside-based drugs targeting ALI, as well as a theoretical basis for the clinical application of Ginseng Radix et Rhizoma in the treatment of ALI.
Ginsenosides/pharmacology*
;
Humans
;
Acute Lung Injury/immunology*
;
Animals
;
Panax/chemistry*
;
Drugs, Chinese Herbal
9.Comparison of side-opening and front-opening approach bone cement injectors in percutaneous kyphoplasty for thoracolumbar osteoporotic vertebral compression fractures.
Wei-Xin DONG ; Zhen-Tao CHU ; Yong HU ; Ou-Jie LAI ; Zhen-Shan YUAN ; Xiao-Yang SUN
China Journal of Orthopaedics and Traumatology 2025;38(2):128-133
OBJECTIVE:
To compare clinical efficacy between side-opening and front-opening bone cement injectors in percutaneous kyphoplasty(PKP) for the management of thoracolumbar osteoporotic vertebral compression fractures(OVCFs).
METHODS:
A retrospective cohort study was conducted, comprising 62 patients with single-segment thoracolumbar OVCFs (T11-L2), who underwent bilateral PKP at our department during the period from June 2020 to October 2021. Patients were categorized into two groups based on the specific bone cement injector employed during the surgical procedure: the side-opening group (n=29) and the front-opening group (n=33). Among them, the side-opening group consisted of 6 male and 23 female patients, with a mean age of (73.32±9.11) years. The front-opening group included 7 male and 26 female patients, with a mean age of (71.29±10.39) years. The variables encompassed essential patient characteristics were recorded, such as gender, age, bone mineral density (BMD), and fracture level (T11-L2), as well as procedural aspects, including operation duration, cement injection volume, cement distribution type (lobular or diffuse), occurrence of cement leakage, pre-and post-operative visual analogue scale (VAS) pain scores, and vertebral compression ratio.
RESULTS:
All patients underwent successful surgery, with a mean follow-up duration of (15.37±3.03) months. There were no statistically significant differences in gender, age, BMD, fracture level, preoperative vertebral compression degree, and VAS scores between the side-opening group and the front-opening group (P>0.05). The operation time, the mean cement injection volumes, the distribution of bone cement within the vertebrae has no statistically significant difference between two groups(P>0.05). Both the side-opening and front-opening groups showed significant improvements in VAS scores at 3 days and 6 months after operation (P<0.05). However, there was no significant difference in VAS scores between the two groups at both 3 days and 6 months after the operation (P>0.05).
CONCLUSION
Side-opening bone cement injectors in bilateral PKP surgery for single-segment thoracolumbar OVCF achieve similar clinical efficacy as front-opening injectors, without significant improvement in cement distribution and containment.
Humans
;
Female
;
Male
;
Kyphoplasty/instrumentation*
;
Aged
;
Bone Cements
;
Fractures, Compression/surgery*
;
Retrospective Studies
;
Spinal Fractures/surgery*
;
Thoracic Vertebrae/injuries*
;
Lumbar Vertebrae/injuries*
;
Osteoporotic Fractures/surgery*
;
Middle Aged
;
Aged, 80 and over
10.Meta-analysis of Kirschner's needle and elastic intramedullary nail fixation for the treatment of proximal humeral fractures in children.
Tao SHI ; Zi-Hang XU ; Xin ZHANG ; Yu-Wang QIAN ; Lei ZHU ; Lai-Fa KONG
China Journal of Orthopaedics and Traumatology 2025;38(6):633-640
OBJECTIVE:
To systematically evaluated clinical efficacy of Kirschner's needle and elastic intramedullary nail fixation in treating proximal humeral fractures in children by Meta-analysis.
METHODS:
Literature on the treatment of proximal humeral fractures in children with Kirschler needles and elastic intramedullary nails published on Wanfang, VIP, CNKI and China biology medicine (CBM), PubMed, Embase, and Web of Science databases were searched from the establishment of databases to October, 2023. Literature extraction, management and data entry were performed by Endnote X9 and Excel 2019, and Meta-analysis was conducted by RevMan 5.3 software. The operation time, hospital stay, fracture healing time, shoulder joint extension range of motion, disabilities of arm, shoulder and hand(DASH) questionnaire score, Neer score or Constant-Murley score and complications were compared between two groups.
RESULTS:
A total of 7 literatures were included, 1 was prospective study, 6 were retrospective cohort study. There were 521 children, 264 children in Kirschner wire group and 257 children in elastic intramedullary nail fixation group. The results of Meta analysis showed operation time[WMD=-12.61, 95%CI(-24.89, -0.33), P=0.04], fracture healing time[WMD=-0.26, 95%CI(-0.49, -0.02), P=0.03], total complication rate [OR=6.83, 95%CI(3.33, 14.01), P<0.001], nail tract infection rate[OR=6.77, 95%CI(1.72, 26.69), P=0.006] and displacement fracture rate[OR=3.57, 95%CI(1.35, 9.44), P=0.01] between two groups had statistically differences(P>0.05), while there were no statistically significant difference in comparison of hospital stay, shoulder joint extension range of motion, DASH, Neer score, Constant-Murley score, and incidence of skin irritation between two groups (P>0.05).
CONCLUSION
Kirschner's needle internal fixation has a short operation time and simple operation, but it has a higher incidence of complications compared with elastic nail internal fixation technique. In terms of efficacy and safety, elastic intramedullary nail fixation is one of the options for the treatment of proximal humeral fractures in children.
Humans
;
Fracture Fixation, Intramedullary/instrumentation*
;
Child
;
Shoulder Fractures/physiopathology*
;
Bone Nails
;
Bone Wires
;
Male
;
Needles
;
Female

Result Analysis
Print
Save
E-mail